overview of the tourmaline-mm1 study in relapsed/refractory multiple myeloma
Published 8 years ago • 152 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
4:48
overview of the final analysis of the phase iii tourmaline-mm1 trial
-
1:40
long-term follow-up of the tourmaline-mm1 trial
-
2:21
tourmaline-mm1 study produces optimistic results for mm
-
7:15
endeavour, aspire and tourmaline-mm1 trial results for multiple myeloma
-
1:33
post-hoc analysis of tourmaline-mm1 data while adjusting for subsequent therapies
-
32:11
barbara dutrow (keynote): “tourmaline and geologic evolution”
-
46:00
tourmaline as a gemstone
-
2:30
what is the lumen metabolism tracker?
-
2:36
what does the tourmaline-mm2 study tell us about the use of ixazomib in multiple myeloma?
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma
-
0:59
defining the origins of multiple myeloma
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
2:22
recent drug approvals for the treatment of relapsed/refractory multiple myeloma
-
1:12
dr. kumar on tourmaline-mm1 study for multiple myeloma
-
5:35
treatment at first relapse in multiple myeloma: how to choose a drug?
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
3:36
tourmaline-al1: ixazomib for al amyloidosis
-
1:24
only the beginning of precision medicine and multiple myeloma.
-
1:46
ctc whole-genome sequencing vs fish to monitor the emergence of multiple myeloma high-risk subclones
-
10:11
monumental-1: talquetamab in r/r multiple myeloma
-
2:01
evolution of the multiple myeloma therapeutic landscape
-
1:59
3-year update on the eloquent-2 clinical trial of elotuzumab in multiple myeloma